Arviatechnology
Founded 2007 Β· 40 employees on LinkedIn Β· 1 known investors
Arvia Technology designs and manufactures wastewater treatment systems that remove persistent organic chemicals from industrial effluent across pharmaceutical, chemical, agricultural, and aquaculture sectors. The company's patented Nyex technology combines adsorption and electrochemical oxidation to achieve low-energy, chemical-free tertiary treatment for water reuse and discharge compliance.
Also known as Arvia Β· Arvia Technology Ltd.
Investors Β· 1
Company profile
researched Aug 2026Arvia Technology is a tertiary water treatment company that designs, manufactures and supplies systems removing persistent organic contaminants and colour from industrial water and wastewater. Its Nyex range applies a patented advanced oxidation process combining adsorption with electrochemical oxidation in a single step; the adsorption media regenerates in situ during operation, so media does not need to be removed, trucked away or thermally regenerated as with granular activated carbon. The company states the process requires no chemical dosing, produces no toxic sludge, has no moving parts, can be switched on and off as required and uses less energy than conventional advanced oxidation processes because of the adsorption/oxidation combination.
The product line includes Nyex Rosalox (adsorption plus electrochemical oxidation), Nyex Ellenox (electrochemical oxidation without adsorption) and Nyex Florenox, an electrochemical oxidation system aimed at PFAS in water. Systems are offered in a range of sizes, as standalone units or as add-ons integrated into existing treatment trains. Applications marketed by the company include API and micropollutant removal, recalcitrant COD reduction, colour removal, blowdown and RO reject water treatment, water reuse and zero liquid discharge, avoidance of wastewater incineration, point-of-entry and drinking water treatment, and AMR-related treatment. Alongside equipment, Arvia offers water testing, treatability trials and wastewater plant hire, and runs an EPC partner programme.
Sectors served include life sciences (pharma, CDMOs, biotech, biopharma, animal health), specialty and petrochemicals, agrochemicals, industrial manufacturing, battery recycling, textiles, hi-tech and semiconductors, utilities, waste management and aquaculture, where the systems are used to remove sea-lice treatment pesticides, medicines and off-flavours in recirculating aquaculture systems.
Founding story
The company was spun out of the University of Manchester's School of Chemical Engineering and Analytical Science by Nyex inventor and founder Dr Nigel Brown together with Dr Ted Roberts. Dr Brown was working on adsorption technologies and identified the cost and disruption of removing adsorption media from site for regeneration as the central problem; the aim was a technology that regenerated the adsorption material in situ, lowering operating cost and environmental impact. After repeated testing and modification this became the Nyex Rosalox system.
Business model
Arvia designs, manufactures and supplies wastewater treatment equipment and bespoke onsite treatment systems to industrial customers, supported by services such as water testing, treatability trials and wastewater plant hire. It also works through EPC partners.
Sale of wastewater treatment systems and equipment, plus related services including water testing, treatability trials and plant hire.
Traction
Arvia reports systems most successfully applied in pharmaceutical, specialty chemical and agrochemical sectors, and cites customer testimonials including a US pharmaceutical company on API residue treatment and Zestron China, which reported R&D results on removal of 1-Phenoxy-2-propanol and a move toward piloting. Press coverage in July 2018 reported the company securing its first treatment deal in China. An external profile estimated 42 employees and annual revenue of $10M-$25M as of July 2026, while another estimated 21-50 employees and annual revenue of about $179,006; these third-party estimates conflict.
Latest developments
Arvia launched Florenox, an electrochemical oxidation system designed to eliminate PFAS in water, in March 2025. In May 2022 it worked with Lancaster University under the Low Carbon Eco-Innovatory business support programme aimed at reducing carbon emissions and accelerating growth.
βΈFull profile β market position, technology, go-to-market, geography, history
Market position
Arvia positions itself as a specialist in tertiary industrial wastewater treatment for persistent organic pollutants, with third-party profiles describing it as a small- to mid-sized environmental services company in the North West of England.
In-situ regeneration of the adsorption media, stated to make the process as effective as granular activated carbon without media replacement or off-site regeneration, combined with no chemical dosing, no toxic sludge, no moving parts, on/off operability and lower energy consumption than conventional advanced oxidation.
Technology
The Nyex process is an advanced oxidation process that couples adsorption with electrochemical oxidation in one unit. Pollutants adsorbed onto the media are oxidised in situ, regenerating the media continuously and converting pollutants to gases that are vented, which the company says avoids media replacement, chemical dosing and toxic sludge while lowering energy use relative to other AOPs. Products include Nyex Rosalox, Nyex Ellenox and Nyex Florenox for PFAS; earlier materials referred to Nyex-a and Nyex-e technologies.
Go-to-market
Direct consultative sales, including free industrial wastewater consultations, engineering assessment of the customer's water profile, treatability trials to scope a pilot, and optioneering to select a solution; the company also publishes case studies and works with EPC partners.
Industrial water users with persistent organic chemicals in their effluent, principally pharmaceutical and life sciences manufacturers and CDMOs, specialty chemical and agrochemical producers, battery recycling, manufacturing, semiconductors, textiles, utilities, waste management and aquaculture operators.
Geography
Headquarters and manufacturing, laboratory, commercial and technical teams are in Runcorn, Cheshire, UK (7 Christleton Court, Manor Park, WA7 1ST). The company also lists a US office in New Smyrna Beach, Florida, and an office and lab facility in Shanghai, China. It reports representatives worldwide, and one profile describes employees across Europe, Asia and North America.
History
Arvia began as a spin-out from the School of Chemical Engineering and Analytical Science at the University of Manchester. Third-party company profiles give a founding year of 2007. The original Nyex product was developed into a range of systems of different sizes by an in-house R&D team. Simon Gatcliffe joined as Chief Executive Officer in November 2020. The company was part of the Unreasonable venture community from November 2017 to February 2021. In March 2025 it launched Florenox, an electrochemical oxidation system targeting PFAS.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 6
launches, deals, and filingsArvia Technology introduced Florenox, an electrochemical oxidation system designed to eliminate PFAS in water.
Runcorn-based Arvia Technology teamed up with Lancaster University as part of the Low Carbon Eco-Innovatory (LCEI) business support programme, which helps companies reduce carbon emissions and accelerate growth.
Simon Gatcliffe joined Arvia Technology as Chief Executive Officer.
Press coverage reported that Runcorn-based Arvia Technology secured its first treatment deal in China.
Arvia Technology was named a finalist in the AkzoNobel Imagine Chemistry award.
Arvia Technology was an Unreasonable venture from November 2017 until February 2021, after which it was no longer part of the community.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Arviatechnologyarviatechnology.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Arviatechnology do?
- UK tertiary wastewater treatment company whose patented Nyex systems remove persistent organic pollutants from industrial effluent.
- Who are Arviatechnology's investors?
- Arviatechnology's investors include Parkwalk Advisors.
